Bladder Cancer
Bladder cancer is a condition characterized by the abnormal growth and replication of malignant epithelial cells in the tissues of the urinary bladder, leading to symptoms such as blood in the urine, pain with urination, and low back pain.
Health Outcomes
- Activated p53/BAX-Mediated DNA Damage Response
- Delayed Tumor Onset
- Enhanced Anticancer Capacity
- Enhanced Antitumor Immunity
- Enhanced CD8+ T Cell Infiltration
- Enhanced Natural Killer Cell Activity
- Enhanced Natural Killer Cell Tumor Killing Activity
- Genitourinary Adverse Events
- Improved Chemotherapy Efficacy
- Improved Chemotherapy Outcome
- Improved Chemotherapy Sensitivity
- Improved Complete Response Rate
- Improved Cure Rate
- Improved Effectiveness in Cancer Treatment
- Improved Intravesical Recurrence-Free Survival
- Improved Natural Killer Cell Activation
- Improved Oncolytic Virotherapy Efficacy
- Improved Overall Survival
- Improved Progression-free Survival
- Improved Response to Immune Checkpoint Inhibitor Therapy
- Improved Response to PD-1 Immunotherapy
- Improved Survival Capacity
- Improved Survival Rate
- Improved Tumor Response
- Improved Urinary Tract Complication
- Improved Urogenital Tract Symptoms
- Inactivated Other Receptor Tyrosine Kinase Activity
- Increased Binding of Carcinogenic Compounds
- Increased Cell Death
- Increased DNA Repair Activity
- Increased Intratumoral CD8+ T-cell Expansion
- Increased Paclitaxel Dose Completion
- Increased Polyamine Levels
- Increased Telomere Length
- Increased Tissue Invasion
- Inhibited Epithelial-Mesenchymal Transition
- Inhibited PI3K/AKT Pathway
- Occurrence of Unrelated Haematuria
- Protected Bladder Microbiome
- Reduced Apoptosis Due to Carcinogens
- Reduced Benzo(a)pyrene Levels
- Reduced Bladder Cancer Risk
- Reduced CEA Levels
- Reduced Cancer Progression
- Reduced Cancer Risk
- Reduced Caspase-3 Activity
- Reduced Cell Adhesion
- Reduced Chemotherapy-Induced Nausea and Vomiting
- Reduced Cumulative Incidents of CIDs in Smokers
- Reduced Disease Recurrence
- Reduced Epithelial-Mesenchymal Transition
- Reduced Hydronephrosis
- Reduced Neutropenia Risk
- Reduced Recurrence
- Reduced Recurrence Rate
- Reduced Recurrence Risk
- Reduced Tumor Activity
- Reduced Tumor Downstaging
- Reduced Tumor Formation
- Reduced Tumor Grade
- Reduced Tumor Growth
- Reduced Tumor Marker Level
- Reduced Tumor Stage
- Reduced Tumor Volume
- Reduced Urinary Dysfunction
- Reduced Urinary Urgency
- Reduced p16 Expression
- Reduced p53 Protein Expression
- Reduced p53 mRNA Expression
- Selective Sparing of Normal Urothelial Cells
- Targeted Tumor Reduction